# The U.S. FDA has announced plans to seek input on repurposing approved drugs.

*biotech · news · 2026-05-12 · Devdiscourse*

## Key points

- FDA plans to seek public input on repurposing approved drugs for wider disease applications.
- Lundbeck raised its 2026 sales forecasts due to U.S. demand and delayed generic competition.
- Roche received a second European regulatory approval for its Alzheimer's blood test developed with Eli Lilly.
- Cellular Intelligence, backed by Mark Zuckerberg, acquired a Parkinson's cell therapy from Novo Nordisk.

**Companies:** H. Lundbeck, Roche, Eli Lilly, Cellular Intelligence, Novo Nordisk
**Countries:** United States, Denmark, Germany

[Read the full story on Devdiscourse](https://www.devdiscourse.com/article/health/3905368-global-health-highlights-innovations-outbreaks-and-pharmaceutical-progress)

---

Canonical: https://newsio.io/n/4b5f4d9d-ec2f-4eba-99a1-3a02a4e5ae92/the-u-s-fda-has-announced-plans-to-seek-input-on-repurposing-approved-drugs-dani
Summarized by Newsio from Devdiscourse. https://newsio.io/how-it-works